Century Therapeutics, Inc.
Century Therapeutics, Inc.（IPSC）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
ipsc · 股价预测 · 9 位分析师（近3月）· FMP · 更新于 2026年6月9日
分析师评级与共识
基于过去 3 个月内 9 位华尔街分析师
Buy
9 位分析师
共识
评级分布
12 个月目标价
High
$4.00
Consensus
$3.00
+41.5% upside
Low
$2.00
Median: $3 · Last Close: $2.12
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$3.00
41.5% upside
High Target
$4
88.7%
Low Target
$2
-5.7%
Current Price
$2.12
as of today
Based on analyst price targets, the IPSC stock price prediction for the next 12 months ranges from $2 to $4. The consensus IPSC price forecast of $3.00 implies 41.5% upside from the current price of $2.12.
短期股价预测
Low Activity算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $2.06 | ↓ 3.06% |
1-day model range: $2.02–$2.09. Peak: $2.09 (-3.06%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · IPSC · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-21 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-01-20 | Piper Sandler | Maintains | Overweight→Overweight |
| 2025-11-17 | Leerink Partners | Downgrade ↓ | Outperform→Market Perform |
| 2025-05-16 | Chardan Capital | Maintains | Buy→Buy |
| 2025-04-03 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-28 | Guggenheim | Maintains | Buy→Buy |
| 2025-03-24 | Chardan Capital | Maintains | Buy→Buy |
| 2025-03-21 | Guggenheim | Maintains | Buy→Buy |
| 2025-03-20 | Piper Sandler | Maintains | Overweight→Overweight |
| 2025-01-22 | Guggenheim | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Century Therapeutics, Inc. (IPSC) stock. Of the recent 38 rating actions, 0 were upgrades and 2 were downgrades. 9 analysts currently cover IPSC.
分析师推荐趋势
IPSC analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 4 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$5M
↑ 300.2% YoY
Revenue Next Year
$4M
↓ 20.9% YoY
EPS This Year
$-0.46
EPS Next Year
$-0.45
↓ 2.9% YoY
EPS ForecastReported vs Estimated
Analysts forecast IPSC EPS of $-0.46 for the current fiscal year, based on estimates from 3 analysts. The IPSC revenue forecast is $5M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
IPSC 股价预测由两类独立数据源支撑：来自 9 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。IPSC 的共识目标价为 $3.00（+41.5% 上行空间），分析师共识为 Buy。
IPSC 的短期预测（明日）为 $2.06（-3.06%）。
Century Therapeutics, Inc. 在 NASDAQ 上市，代码 IPSC。IPSC 在 2027 年的整体展望偏积极，在覆盖分析师中约 78% 对应 Buy 共识。
常见问题
IPSC 预测 · 8 个问题根据 9 位华尔街分析师，IPSC 的 12 个月平均目标价为 $3.00，最高 $4.00、最低 $2.00。若有图表，中位目标价可在上方查看。相对当前价 $2.12，隐含约 +41.5% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.